What is a stock summary page? Click here for an overview.
Business Description
Philogen SpA
NAICS : 325412
ISIN : IT0005373789
Compare
Compare
Traded in other countries / regions
PHIL.Italy78Q.GermanyPHILm.UK IPO Date
2021-03-08Description
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.64 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | -0.54 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 17.19 | |||||
| Beneish M-Score | -2.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 63.7 | |||||
| 3-Year EBITDA Growth Rate | 44.2 | |||||
| 3-Year EPS without NRI Growth Rate | 16.2 | |||||
| 3-Year FCF Growth Rate | 16.7 | |||||
| 3-Year Book Growth Rate | 17.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.59 | |||||
| 9-Day RSI | 57.69 | |||||
| 14-Day RSI | 56.3 | |||||
| 3-1 Month Momentum % | -4 | |||||
| 6-1 Month Momentum % | -6.74 | |||||
| 12-1 Month Momentum % | 3.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.22 | |||||
| Quick Ratio | 5.02 | |||||
| Cash Ratio | 4.48 | |||||
| Days Inventory | 49.65 | |||||
| Days Sales Outstanding | 159.22 | |||||
| Days Payable | 158.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | 0.02 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -728.02 | |||||
| Operating Margin % | -1415.89 | |||||
| Net Margin % | -1284.98 | |||||
| FCF Margin % | -1350.79 | |||||
| ROE % | -32.46 | |||||
| ROA % | -24.53 | |||||
| ROIC % | -97.54 | |||||
| 3-Year ROIIC % | 43.84 | |||||
| ROC (Joel Greenblatt) % | -118.17 | |||||
| ROCE % | -27.73 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 10.56 | |||||
| PS Ratio | 343.86 | |||||
| PB Ratio | 10.41 | |||||
| Price-to-Tangible-Book | 10.62 | |||||
| EV-to-EBIT | -25.14 | |||||
| EV-to-EBITDA | -28.8 | |||||
| EV-to-Revenue | 323.63 | |||||
| EV-to-FCF | -23.96 | |||||
| Price-to-GF-Value | 0.25 | |||||
| Price-to-Net-Current-Asset-Value | 17.03 | |||||
| Price-to-Net-Cash | 21.98 | |||||
| Earnings Yield (Greenblatt) % | -3.98 | |||||
| FCF Yield % | -3.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Philogen SpA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2.284 | ||
| EPS (TTM) (€) | -0.73 | ||
| Beta | 0.05 | ||
| 3-Year Sharpe Ratio | 0.37 | ||
| 3-Year Sortino Ratio | 0.6 | ||
| Volatility % | 25.78 | ||
| 14-Day RSI | 56.3 | ||
| 14-Day ATR (€) | 0.595331 | ||
| 20-Day SMA (€) | 18.44 | ||
| 12-1 Month Momentum % | 3.45 | ||
| 52-Week Range (€) | 16.1 - 22 | ||
| Shares Outstanding (Mil) | 40.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Philogen SpA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Philogen SpA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Philogen SpA Frequently Asked Questions
What is Philogen SpA(STU:78Q)'s stock price today?
The current price of STU:78Q is €18.90. The 52 week high of STU:78Q is €22.00 and 52 week low is €16.10.
When is next earnings date of Philogen SpA(STU:78Q)?
The next earnings date of Philogen SpA(STU:78Q) is .
Does Philogen SpA(STU:78Q) pay dividends? If so, how much?
Philogen SpA(STU:78Q) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers